Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells (original) (raw)
- Original Paper
- Published: 06 February 1997
Oncogene volume 14, pages 595–602 (1997)Cite this article
- 579 Accesses
- 93 Citations
- 6 Altmetric
- Metrics details
Abstract
Invasive cervical cancer is very highly correlated with the presence of high-risk human papillomavirus (HPV) types 16 and 18. Two viral proteins, E6 and E7, act in concert to subvert growth control of infected cells by inactivating the tumor suppressor proteins, p53 and Rb, respectively. E6 is thought to abrogate p53 function by stimulating its degradation via ubiquitin-mediated proteolysis in a reaction requiring E6AP (E6-Associated Protein). Here we evaluate the in vivo role of E6AP in p53 degradation in normal and HPV-infected cell types using antisense phosphorothioate oligodeoxynucleotides (S-ODNs). This study shows that reduction of E6AP in vivo in high-risk HPV-infected cells leads to an elevation of p53, confirming the function of E6AP predicted by in vitro experiments. Further, we demonstrate that reduction of E6AP in normal cells has no effect on p53 levels, indicative of an E6AP-indpendent mechanism for p53 degradation. These experiments show that inhibition of intermediate proteins in the ubiquitin-mediated proteolysis pathway (ubiquitin-conjugating enzymes or associated recognition proteins) can result in specific inhibition of substrate degradation. We propose that modulation of p53 levels by elimination of E6AP function may have therapeutic potential for cervical cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Mitotix Inc, One Kendall Square, Building, Cambridge, 600, O2139, Massachusetts, USA
Peggy Beer-Romero, Susan Glass & Mark Rolfe
Authors
- Peggy Beer-Romero
You can also search for this author inPubMed Google Scholar - Susan Glass
You can also search for this author inPubMed Google Scholar - Mark Rolfe
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Beer-Romero, P., Glass, S. & Rolfe, M. Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells.Oncogene 14, 595–602 (1997). https://doi.org/10.1038/sj.onc.1200872
- Received: 22 July 1996
- Revised: 08 October 1996
- Accepted: 08 October 1996
- Issue Date: 06 February 1997
- DOI: https://doi.org/10.1038/sj.onc.1200872